EMBRAZE

What EMBRAZE does

EMBRAZE Kankernetwerk is a regional oncology care network headquartered in Breda, Netherlands, coordinating cancer care across 7 hospitals (ADRZ, Amphia, Bravis, Erasmus MC, ETZ, Jeroen Bosch, ZorgSaam) and 2 radiotherapy institutes (Instituut Verbeeten, ZRTI) in the Brabant and Zeeland provinces. The network formalizes multidisciplinary team meetings (MDOs), Network Tumor Groups (NTGs), and shared clinical standards so that patients receive coordinated oncological care close to home with escalation to specialized centers when necessary.

The core digital infrastructure includes the MDO Platform Vitaly (a 2025 launch optimizing multidisciplinary consultation data exchange, funded via IZA transformation grants approved by CZ and VGZ), XDS Cross-Enterprise Document Sharing for radiology images and reports between member institutions, and the Noona patient-reported outcome measures application deployed at ZRTI. Member hospitals additionally integrate EMBRAZE workflows with electronic patient records (ChipSoft) and imaging exchange (TWIIN). The network is governed by an Algemeen Bestuur (General Board) of hospital board representatives, a Netwerkoncologiecommissie providing expert advisory input, and tumor-specific NTGs that drive clinical protocols.

EMBRAZE operates as a non-profit coordination organization without equity investors; funding flows through the Dutch healthcare insurance system and IZA transformation funds rather than direct patient billing. Go-to-market is community-led, anchored on institutional membership and clinical leadership engagement rather than sales activity. The coordination team is small (medical coordinator, general coordinator, management assistant, communications advisor), with MDO volume reaching 71,464 patient discussions in 2021, up from 40,456 in 2018.

Name

EMBRAZE

Legal name

EMBRAZE Kankernetwerk

Website

https://embraze.net

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

EMBRAZE is a regional oncology network in South-West Netherlands coordinating multidisciplinary cancer care across 7 hospitals and 2 radiotherapy institutes, funded through the Dutch healthcare system and IZA transformation grants.

Ownership category

akta.pro rank

Product category

Oncology Care Network

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), General Medical and Surgical Hospitals (622110)

SIC

Services-Health Services (8000)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Virtual Care Team Collaboration & Provider-to-Provider Teleconsult Platforms (eConsults) (HLALABAI), eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Cancer care coordination
• Oncology network management
• Multidisciplinary consultations
• Regional health network
• Radiotherapy coordination

Headquarters

HQ city

Breda

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Healthcare Service Coordination: EMBRAZE functions as a coordination network for oncology care across regional hospitals. The network receives funding through the Dutch healthcare system, including transformation funds from the Integraal Zorgakkoord (IZA) approved by health insurers CZ and VGZ for MDO platform implementation. Revenue derives from healthcare funding mechanisms rather than direct patient billing.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

EMBRAZE is a regional oncology network that coordinates cancer care across 7 hospitals and 2 radiotherapy institutes in South-West Netherlands (Brabant and Zeeland). It facilitates multidisciplinary team meetings (MDOs) where oncological patients are discussed, standardizes care via network tumor groups (NTGs), enables digital data sharing between specialists through the MDO Platform Vitaly and XDS systems, and provides case management support to ensure consistent, high-quality cancer treatment close to home.

Product overview

EMBRAZE is a regional cancer care network (kankernetwerk) comprising seven hospitals and two radiotherapy institutes in Southwest Netherlands (Brabant and Zeeland). The network operates as a coordination and collaboration platform for oncological care, connecting specialists from Amphia, Elisabeth-TweeSteden Ziekenhuis (ETZ), Jeroen Bosch Ziekenhuis, Bravis ziekenhuis, ADRZ, ZorgSaam, Erasmus MC, and radiotherapy institutes Instituut Verbeeten and ZRTI. The core offering includes network coordination, knowledge sharing, and quality assurance across the cancer care continuum. Key digital components include the MDO Platform Vitaly for multidisciplinary consultations and Noona for patient-reported outcome measures. The network facilitates care pathways for various cancer types including breast, prostate, bladder, colorectal, renal, head and neck, and others.

Differentiator

Problem solved

Functional benefit

Products and services

• EMBRAZE Kankernetwerk (Cancer Network) A regional cancer care network coordinating oncological care across seven hospitals (ADRZ, Amphia, Bravis, Erasmus MC, ETZ, Jeroen Bosch, ZorgSaam) and two radiotherapy institutes (Instituut Verbeeten, ZRTI) in South-West Netherlands. The network coordinates multidisciplinary team meetings (MDOs), facilitates knowledge sharing among oncology professionals, standardizes treatment protocols via network tumor groups (NTGs), and provides case management support to ensure patients receive high-quality cancer care close to home.
• MDO Platform Vitaly A digital platform for multidisciplinary team consultations (MDOs) that enables data sharing between specialists from participating institutions, optimizing the preparation and processing of oncological patient discussions across the network. Patient information is collected and distributed to all MDO participants, and MDO outcomes are directly integrated into patient records, replacing manual transcription.

Quantifiable outcome

• MDO patient discussions grew from 40,456 in 2018 to 71,464 in 2021
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature3 records

Partnerships

Ten partnerships are on record, tiered major and core.

• CONCORD (Oncologienetwerk Zuidwest Nederland)majorStrategic or Co-development Partner · 1 October 2019CCN Zuidwest Nederland alliance of EMBRAZE and CONCORD networks. Jointly organizes regional policy tables, educational events, and coordinates oncology network development. Represents combined network collaboration in the South-West Netherlands region.
• Amphia ZiekenhuiscoreStrategic or Co-development Partner · 1 April 2016Amphia Ziekenhuis in Breda is one of the 7 founding hospital partners in the EMBRAZE network. Hosts network coordination office. Representatives serve on the General Board and participate in network tumor groups.
• Elisabeth-TweeSteden Ziekenhuis (ETZ)coreStrategic or Co-development Partner · 1 April 2016ETZ in Tilburg and Waalwijk is a founding network partner and tertiary care center within the region. Offers specialized services including Gamma Knife Center and head/neck cancer treatment. Assumed Nuclear Medicine department from Instituut Verbeeten in April.
• Jeroen Bosch Ziekenhuis (JBZ)coreStrategic or Co-development Partner · 1 April 2016JBZ in Den Bosch is a founding network partner. Hosts prostate cancer surgeries as part of regional urology collaboration. Implemented digital XDS data exchange with Instituut Verbeeten.
• Bravis ZiekenhuiscoreStrategic or Co-development Partner · 1 April 2016Bravis Ziekenhuis in Roosendaal and Bergen op Zoom is a founding network partner. Collaborates with Amphia on urological oncology. Implemented digital XDS data exchange with ZRTI.
• ADRZ (Algemeen Ziekenhuis Rotterdam e.o.)coreStrategic or Co-development Partner · 1 April 2016ADRZ is a founding network partner serving the Zeeland region.
• ZorgSaamcoreStrategic or Co-development Partner · 1 April 2016ZorgSaam serves Zeeuws-Vlaanderen region. Willem van den Adel joined as board member representing ZorgSaam on the General Board from June.
• Erasmus MCcoreStrategic or Co-development Partner · 1 April 2016Erasmus MC in Rotterdam serves as the tertiary/academic center in the network. Stefan Sleijfer chairs the board. Houses Erasmus MC Kanker Instituut providing specialized cancer treatment.
• Instituut VerbeetencoreStrategic or Co-development Partner · 1 April 2016Instituut Verbeeten in Tilburg is a founding radiotherapy institute partner. Transferred Nuclear Medicine department to ETZ in April. Implemented digital XDS exchange with JBZ.
• Zuidwest Radiotherapeutisch Instituut (ZRTI)coreStrategic or Co-development Partner · 1 April 2016ZRTI is a founding radiotherapy institute partner serving South-West Netherlands. Treats approximately 2,000 patients annually. First Dutch healthcare organization to implement Noona app. Implemented XDS exchange with Bravis.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• IKNL (Integraal Kankercentrum Nederland): IKNL is the Netherlands' national comprehensive cancer network organization supporting oncology research, registries, and trial coordination. It operates at a broader national scope than EMBRAZE but addresses overlapping value (cancer care coordination, outcome data, and multidisciplinary standards).
• Erasmus MC Cancer Institute: Erasmus MC Cancer Institute is a Dutch academic tertiary cancer center and an EMBRAZE member. It represents the broader academic hospital model in Dutch oncology, comparable in clinical capabilities though not in network coordination focus.
• Netherlands Cancer Institute (NKI): NKI is a leading Dutch comprehensive cancer center and research hospital. While focused on patient care and research rather than regional coordination, it is a major system player in Dutch oncology alongside EMBRAZE's member Erasmus MC.

Emerging players

• Navya Network: Navya is an online platform for oncology treatment decision support and multidisciplinary consultations. Comparable to EMBRAZE's MDO model in addressing the need for multidisciplinary expert input on complex cancer cases.
• Noona (Varian / Siemens Healthineers): Noona is a patient-reported outcomes (PROMs) platform used by ZRTI within the EMBRAZE network. Acquired by Varian (now Siemens Healthineers), it provides comparable patient engagement technology for oncology care paths.
• OncoLens: OncoLens is a US-based cloud platform for multidisciplinary tumor boards and oncology care coordination. It competes in the same MDO/tumor board software category as EMBRAZE's MDO Platform Vitaly, targeting a similar enablement use case across health systems.

Regional players

• German Comprehensive Cancer Centers (CCC) Network: The German CCC network is a coalition of oncological top centers coordinating cancer care across German regions. Operates in a different country but addresses the same regional oncology coordination value proposition as EMBRAZE.

Others

• ZorgKeuzeLab: ZorgKeuzeLab is a Dutch shared decision-making tool provider partnered with EMBRAZE for prostate cancer choice aids. Functions as an enabler within the EMBRAZE ecosystem rather than a direct competitor.
• Univadis (Medscape) Oncology Resources: Univadis provides clinical decision support and oncology knowledge resources to physicians. Adjacent to EMBRAZE's knowledge-sharing and continuous professional development role within network tumor groups.

Direct peers

• CONCORD (Oncologienetwerk Zuidwest Nederland): CONCORD is the sister oncology network in South-West Netherlands, partnering with EMBRAZE in the CCN Zuidwest Nederland alliance. Both networks operate regional oncology coordination models across overlapping hospital memberships, making them the most direct comparable.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/embraze
• LinkedInlinkedin.com/company/embraze-kankernetwerk

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EMBRAZE